2026 Age of AI Europe Post-Event Report

What pharma leaders shared, and what it means for you
Download the free report NOW

Frree Report:
See how the AI shift has happened in Pharma.

- This free report captures what was shared, debated, and demonstrated on at the 2026 Europe Age of AI event. It was designed to be a working document: session summaries with specific takeaways, named case studies, verbatim quotes from speakers, and a cross-cutting executive summary of the six things every pharma leader needs to act on now.

- Insights from 25 speakers. 15 sessions, including leaders at Bayer, Vertex, AstraZeneca, Roche, Novo Nordisk, Recordati, Real Chemistry, Tangram Therapeutics and more…distilled into a practical guide.

- Insights and case studies covering Agents, GEO, workforce motivation, launch excellence and more!

Thank you to Inizio for co-creating the report.

Highlights Include

The question is no longer whether to adopt AI. It's whether you can redesign your organisation around it.
With 78% of executives believing agentic AI requires a completely new operating model, agents are not a feature to add to existing processes. They require new governance, new team structures, and new definitions of accountability.
The EU AI Act compliance clock is running. August 2026 is a hard deadline.
From 2 August 2026, organisations deploying AI in high-risk areas (including clinical decision-making, patient selection, and pharmacovigilance) must demonstrate documented risk management, human oversight, and formal conformity assessments before systems go live.
Your brand is already in AI search results. Whether you've optimised for it or not.
AI is already shaping your brand... without you. Healthcare discovery has entered the synthesis era, and the new metric worth tracking is share of answer: how your brand appears and is interpreted inside AI-generated responses.
Agentic AI is not a future scenario. It has entered clinical trials.
Tangram Therapeutics' first drug candidate discovered using agentic AI has just entered clinical trials, with their LLibra OS platform aiming to move from target nomination to clinical candidate in under 12 months.
The agency-client model is changing. The new currency is trust, not time.
AI means work can move so quickly, the traditional hours-for-deliverables agency model starts to break down. The future relationship won’t be built on time. It will be built on trust, capability and accountable outputs.
In the age of AI, human performance matters more than ever.
The leaders who thrive will be the ones who double down on the fundamentals of focus, trust, and human connection, because while AI is changing how we work, it is people who determine how well we perform.

"The creative economy is dead. What we are transitioning into can best be described as the trust economy."

Duncan Arbour

Head of AI Innovation, Kinetic/Syneos Health

Insights from 25 contributors including:

Benjamin Tilly
Reg Troka
 (
Bayer
)
Christian Gardner
 (
Envision Pharma Group
)
Giulia Bertolini
 (
Bayer
)
Elliot Leavy
 (
Acquainted
)
Louise Ostergaard
 (
Novo Nordisk
)
Amman Ayub
 (
Advanz Pharma
)
Jasmine Agyekum,
 (
Clifford Chance
)
Jo Ann Saitta
 (
Inizio Ignite
)
Tom Paton
 (
AiMation
)
Liz Stutz
Konstantina Patrikiou
 (
Roche
)
Michelle Dunst
 (
Real Chemistry
)
Pav Rishiraj
 (
IPSEN & ABPI Chair of Pharma Convigilance
)
Sara Rodrigues, PharmD
 (
Vertex
)
Timothy Luxford
 (
Inizio Ignite, STEM & Research Partnership
)
Phil Wakefield
 (
Inizio Medical
)
Simon Jeffries
 (
The Natural Edge
)
Agata Kinga Kaczmarek
 (
Recordati
)
Dr. Michelle King
Emma Slade
 (
Tangram Therapeutics
)
Ridwaan Jhetam
 (
BMS
)
Rakesh Kantaria
 (
Circuit Medical
)
Robin Jones
 (
AstraZeneca
)
Duncan Arbour
 (
Kinetic, Syneos Health
)

Who this report is for

This report is written for pharma marketing leaders, medical affairs professionals, agency executives, and commercial teams who are moving beyond AI experimentation and need to know what the leading organisations are actually doing.

Pharma marketing leaders

Medical affairs professionals

Agency executives

Commercial teams

If you are building a business case for AI investment, designing a governance framework, evaluating an agency partner, or trying to understand where GEO fits in your content strategy, this report is directly relevant to your work.

Download the report. It is free!

Download the free report NOW

Thank you to our event partners

© All rights reserved
ContactTerms & ConditionsPartnerPrivacy
Past Events
Creativity Now, 2024 Age of AI Canada, 2024Age of AI Europe, 2025Age of AI Canada, 2025SFE, 2025Medical,  2025Women in AI,  2025Meetup Nov 13, 2025Meetup Dec 1,  2025Age of AI Europe, 2026